(Total Views: 601)
Posted On: 08/26/2018 9:40:53 AM
Post# of 594
Just to reiterate UEEC runs to .1.49 the 18 month high on fda approval easy!
News of an acquisition runs us past $3 then look for a correction. Ultimately this could be a bidding war! Do your d/d the hemostat treatment is not new granted! What is new is the internal surgical use application!
News of an acquisition runs us past $3 then look for a correction. Ultimately this could be a bidding war! Do your d/d the hemostat treatment is not new granted! What is new is the internal surgical use application!
(0)
(0)
